AbbVie cov khoom lag luam nce ntawm cov nyiaj tau los hauv peb lub quarter thib plaub raws li nws tshaj tawm tias kev muag khoom zoo dua li kev cia siab ntawm Humira

Ib qho dhau los ntawm tsab ntawv ceeb toom no tau xa mus rau Humana hauv xov xwm, tsis yog Humira. Nws tau raug kho lawm.

Shares ntawm AbbVie Inc.
ABVV,
+ 0.08%
tau nce 1.4% hauv kev ua lag luam ua ntej hnub Wednesday tom qab lub tuam txhab tuav cov nyiaj tau los ntawm kev cia siab thiab tsim kev muag khoom ntau dua li qhov xav tau ntawm nws cov muag muag tshuaj rheumatoid mob caj dab, Humira. AbbVie tau nyiaj tau los ntawm $ 4.0 nphom, lossis $ 2.26 ib feem, hauv lub quarter thib plaub ntawm 2021, piv nrog $ 36.0 lab, lossis 1 xees ib feem, hauv tib lub hlis twg ib xyoos dhau los. Kho cov nyiaj tau los ntawm ib feem yog $ 3.31, tawm tsam FactSet kev pom zoo ntawm $ 3.28. Lub tuam txhab tau tshaj tawm cov nyiaj tau los ntawm $ 14.8 nphom hauv lub quarter kawg ntawm 2021, piv nrog $ 13.8 nphom nws tau tshaj tawm nyob rau lub quarter thib plaub ntawm xyoo tas los. Qhov kev pom zoo ntawm FactSet yog $ 14.9 billion. Humira tseem yog lub tuam txhab muag tshuaj zoo tshaj plaws, nqa $ 5.3 nphom hauv cov nyiaj tau los hauv lub quarter thib plaub ntawm 2021. Qhov ntawd yog ib feem peb ntawm AbbVie cov nyiaj tau los tag nrho rau peb lub hlis twg. FactSet kev pom zoo rau Humira cov nyiaj tau los yog $ 5.4 billion. AbbVie tau hais tias tam sim no nws cia siab tias yuav tau kho EPS ntawm $ 14.00 txog $ 14.20 hauv 2022. Lub tuam txhab cov khoom lag luam tau nce 32.4% xyoo dhau los, thaum qhov dav S&P 500.
SPX,
+ 0.69%
tau muaj 20.4%.

Tau qhov twg los: https://www.marketwatch.com/story/abbvies-stock-gains-on-fourth-quarter-earnings-as-it-reports-better-than-expected-sales-of-humana-2022-02- 02?siteid=yhoof2&yptr=yahoo